Development of robust clinical decision support systems key to increased adoption across Europe

London 23 August 2006The development of robust clinical decision support systems (CDSS) will propel this nascent market into the growth stage. Rising concerns about patient safety will have a positive impact on market expansion, while increased confidence in the ability of clinical systems to improve health care delivery will support wider uptake. Frost & Sullivan finds that the Clinical Decision Support Systems Markets in Europe earned revenue of $238,5 million in 2005 and estimates this to reach $430,7 million in 2012.

Advertisement

"With patient safety an issue of increasing concern across Europe, vendors must seek to create a strong relationship between clinical decision support (CDS) and enhanced patient safety", stated Frost & Sullivan Research Analyst Kiran John. "Robust, scalable and proven CDSS systems will effectively address the demand for better patient safety."

Developing these robust systems will require extensive testing and product development. Over the next few years, CDS will experience a surge in terms of innovation and product development. CDSS providers are at the forefront of product development, and those who realise the need to offer high-performance CDSS will be best positioned to leverage emerging growth opportunities.

"Health care information technologies (HIT) vendors will have to formulate strategies to increase research on CDSS, and explore new avenues to creatively test CDSS solutions", observed Mr. John. "This dedication to research and development will ensure continued progress in terms of product accuracy and reliability."

However, low awareness levels among health care authorities is discouraging government funded research into CDSS. Hospital IT budgets are relatively inelastic to technological developments such as CDSS, and continue to restrain the HIT market as a whole. "Continual product development and testing will be essential for ensuring greater accuracy, reliability, interoperability and scalability, and encouraging wider uptake", explained Mr John. "CDSS providers capable of delivering solutions with these attributes, stand to win lucrative contracts."

Currently, market participants include large firms offering enterprise solutions with CDS support as well as small-medium vendors, some of whom have single speciality offerings. While large HIT vendors granted IS contracts seek expertise from these speciality firms, small-medium sized speciality CDSS providers are, in turn, benefiting from these alliances in terms of improved visibility.

"Specialist participants already possess the expertise needed to carve distinct niches for themselves", elaborated Mr. John. "However, they will have to concentrate on building strategic alliances, in order to increase their visibility in the industry, as well as to have more effective access to decision makers."

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the Clinical Decision Support Systems Markets in Europe (B984 - 48) you can send an e-mail to Radhika Menon Theodore, Corporate Communications at Frost & Sullivan with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. The information will be sent to you via e-mail upon receipt of the above information.

Clinical Decision Support System Markets in Europe is part of the Healthcare & Life Sciences IT Subscription, which also includes research in the following markets: European Hospital Administrative Systems Market, Competitive Profiles of Key Healthcare IT Firms and European Hospital Information Systems Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.


Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]